Somaxon paces decliners in drug sector
November 19, 2010 at 11:12 AM EST
Somaxon is the drug sector’s lead decliner in early trading Friday after it priced a public stock offering substantially below Thursday’s closing price.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.